Prognostic Value of Bone Scan in Patients With Metastatic Prostate Cancer Treated Initially With Androgen Deprivation Therapy
- 1 October 2002
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 168 (4 Part 1), 1423-1426
- https://doi.org/10.1016/s0022-5347(05)64465-5
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortalityCancer, 2001
- Mechanisms governing bone metastasis in prostate cancerCurrent Opinion in Urology, 2001
- The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinomaCancer, 2000
- Has There Been a Recent Shift in the Pathological Features and Prognosis of Patients Treated With Radical Prostatectomy?Journal of Urology, 1997
- Extent of Disease Based on Initial Bone Scan: Important Prognostic Predictor for Patients with Metastatic Prostatic CancerEuropean Urology, 1995
- Patterns of Bone Metastasis and their Prognostic Significance in Patients with Carcinoma of the ProstateBritish Journal of Urology, 1993
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Multivariate Analysis of Prognostic Factors in Patients with Advanced Prostatic Cancer: Results from 2 European Organization for Research on Treatment of Cancer TrialsJournal of Urology, 1989
- Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scanCancer, 1988
- THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASESAnnals of Surgery, 1940